Back to Dashboard
S-2531Senate2025-07-30Health

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

YourVoice.Now Summary

Your MoneyTransparency & Accountability

States could get federal grants to catch uterine fibroids earlier — but the grants are optional and the bill adds no money.

Your Money

Help paying for fibroid screening — if your state gets a grant

A state with a grant could pay for screening and detailed scans of the uterus. The bill provides no money of its own, so this depends on the Secretary choosing to fund states.

Help finding and getting to fibroid care — only if funded

Grant money could pay for patient navigators. These are staff who help people find a doctor, book visits, and get to the appointment.

Transparency & Accountability

Public reports on the program — posted every two years

Health and Human Services would have to tell Congress what the grants paid for and what the research found. The same reports would go on the department's website, where anyone could read them.

More about this bill

If you have uterine fibroids, your state could one day help pay for the scans that find them. Fibroids are growths in the wall of the uterus. But none of that is guaranteed. The bill lets the Secretary of Health and Human Services give grants to states, but does not require it. It names no dollar amount and adds no money of its own. Any grants would come out of funds Congress already provides. Only states could get these grants, not clinics, hospitals, or patient groups. A state could spend the money on screening and detailed imaging. It could also pay for those procedures, for staff who help people find care, or for public awareness campaigns. A second kind of grant would pay for state research. That covers pain care during fibroid surgery, plus other uterine conditions the Secretary picks. Two duties are firm. The Secretary would have to study how to catch fibroids earlier. That work would then become strategies for the places where people get care. And every two years, the department would have to report the results to Congress and post them online. The bill sets no end date.

Congressional Summary

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 This bill authorizes grants to support early detection of and intervention for uterine fibroids. Uterine fibroids are tumors in the wall of the uterus that are usually benign but can cause painful and heavy menstrual bleeding and other symptoms. The bill requires the Department of Health and Human Services (HHS) to (1) conduct or support research on increasing early detection of and medical intervention for uterine fibroids, and (2) formulate strategies to increase early detection based on such research. Also, the bill authorizes HHS to provide grants to states to increase early detection of and intervention for uterine fibroids (e.g., screenings) and to carry out public awareness campaigns. Additionally, the bill authorizes HHS to provide grants to states for research relating to (1) disparities in pain management in uterine fibroid surgical treatment; or (2) uterine health conditions, as determined appropriate by HHS. HHS must report to Congress every two years on the activities funded by grants under the bill, including findings from the research conducted by states.

Legislative Subjects

Congressional oversightHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsResearch administration and fundingSex and reproductive healthWomen's health

Details

Congress
119th
Chamber
Senate
Status
summarized
Action
Introduced in Senate
Action Date
2025-07-30
Date Added
2026-09-16
Source
Congress.gov →

Like reading a bill in plain English?

We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.

By default, we'll only email you once — when the app launches. Unless you opt in below, you won't receive anything else. We don't share or sell your email.